Streplieve Oral Syrup

What Is Streplieve and What Is It Used For?

Streplieve belongs to the broad therapeutic group known as throat preparations — medicines applied locally to the pharynx and oral cavity to relieve discomfort caused by minor inflammatory or infectious conditions of the upper respiratory tract. This group includes lozenges, sprays, gargles, and, as in the case of Streplieve, oral syrups. The defining feature of such preparations is that their therapeutic action occurs primarily at the site of application rather than through systemic absorption, which gives them a favourable safety profile compared with systemically acting anti-inflammatory or antibiotic medicines.

A sore throat, medically known as pharyngitis, is one of the most common reasons people visit a doctor or pharmacist. In adults, sore throat accounts for an estimated 2–4% of all primary care consultations in high-income countries, and in children the figure is even higher. Most cases — approximately 70 to 90 percent in adults — are caused by respiratory viruses such as rhinovirus, coronavirus, adenovirus, influenza virus, parainfluenza virus, or Epstein-Barr virus. Only a minority are caused by bacteria, most importantly group A beta-haemolytic Streptococcus pyogenes (so-called “strep throat”), which accounts for roughly 5–15% of adult cases and 15–30% of paediatric cases.

Because the vast majority of sore throats are viral and self-limiting, international guidelines issued by the National Institute for Health and Care Excellence (NICE), the Infectious Diseases Society of America (IDSA), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) recommend symptomatic management as the first-line approach and caution against the unnecessary use of systemic antibiotics. This is where topical throat preparations such as Streplieve play an important role: they address the symptom burden that patients find most troubling — pain on swallowing, constant throat irritation, cough, and disturbed sleep — without exposing patients to the adverse effects, resistance risk, and costs of inappropriate antibiotic therapy.

Approved Indications

Streplieve is prescribed for the short-term symptomatic relief of:

• Sore throat (pharyngitis) of viral or non-specific origin, including that associated with the common cold and seasonal upper respiratory tract infections.
• Minor inflammation of the oropharyngeal mucosa, such as may occur after prolonged speaking, smoking, exposure to dry air, air pollution, or passive smoke.
• Throat irritation and hoarseness related to benign laryngopharyngeal irritation, provided serious underlying causes have been excluded by a clinician.
• Adjunctive symptomatic relief in selected patients with bacterial pharyngitis already receiving appropriate antibiotic therapy, to ease local discomfort during the first few days of antibiotic treatment.

It is not indicated as a stand-alone treatment for confirmed or suspected streptococcal sore throat, tonsillar abscess (quinsy), epiglottitis, diphtheria, acute laryngotracheobronchitis, severe candidiasis of the oral cavity, or any condition presenting with stridor, drooling, or inability to swallow saliva. These are medical emergencies or serious conditions that require urgent evaluation and targeted therapy.

How Streplieve Works (Mechanism of Action)

The therapeutic effect of Streplieve is the result of several complementary actions at the level of the pharyngeal mucosa rather than a single pharmacological mechanism. Typical throat preparations in this class combine:

• A local antiseptic component that reduces the bacterial and fungal load on the surface of the throat mucosa, limiting secondary colonisation of inflamed tissue and contributing to odour and taste improvement.
• A local anaesthetic or counter-irritant component that dampens the activity of nociceptive nerve endings in the mucosa, producing a rapid-onset reduction in pain and the urge to cough.
• A demulcent vehicle — typically a viscous syrup base enriched with glycerol, sugar, sorbitol, or similar hygroscopic agents — that forms a protective film over the inflamed surface, maintaining local hydration and reducing mechanical friction during swallowing.

Together, these effects translate into a noticeable reduction in throat pain, a softening of cough episodes driven by pharyngeal tickle, and improved tolerance of food and fluid intake. Onset of action is typically within a few minutes of swallowing the syrup, and effects last from one to several hours depending on the specific formulation and the severity of inflammation.

Pharmacokinetic Profile

Because Streplieve acts locally, systemic exposure to its active substances is limited when used at recommended doses and intervals. Small amounts may be swallowed and absorbed from the gastrointestinal tract, but clinically meaningful systemic levels are not expected with short-term use. This local-action profile is the key reason why throat preparations in this class are generally well tolerated, including in patients taking multiple systemic medicines. Nevertheless, exposure can become clinically relevant if the recommended maximum daily dose is exceeded or if the product is used for a longer period than prescribed.

What Streplieve Does Not Do

What Should You Know Before Taking Streplieve?

Before using Streplieve, it is important to understand the circumstances in which it should not be used, the conditions that require extra caution, and the lifestyle factors that can influence both efficacy and safety. The information below provides a general overview; the product-specific package leaflet supplied with your bottle will always take precedence for details such as exact excipient quantities, specific age thresholds, and manufacturer contact information.

Contraindications

Streplieve must not be used in any of the following situations:

• Known hypersensitivity (allergy) to any of the active substances listed in the product leaflet, to any of the excipients (for example flavouring agents, colouring agents, preservatives, sorbitol, sucrose, or ethanol), or to closely related chemical substances.
• Severe mucosal ulceration or open wounds in the mouth or throat, where the protective barrier is markedly disrupted and absorption may be substantially increased.
• Acute airway compromise: stridor, severe swelling of the tongue or throat, drooling, or difficulty handling saliva. These features can indicate epiglottitis, peritonsillar abscess, or anaphylaxis and require immediate emergency care, not oral syrup.
• Use in infants and very young children below the age limit stated on the package, because of the risk of impairing the swallowing reflex or of accidental overdose.

Warnings and Precautions

Before starting treatment, tell your doctor about your full medical history, including any of the following:

• Diabetes mellitus: Many throat syrups contain sugar, glucose, sucrose, or honey as the base. Frequent dosing throughout the day can contribute meaningfully to carbohydrate intake and may destabilise blood glucose control. If you have diabetes, ask your pharmacist whether a sugar-free version of the product is available, and monitor blood glucose more closely during treatment.
• Hereditary fructose intolerance (HFI): Patients with HFI must not use syrups containing sucrose, fructose, or sorbitol (E420). Symptoms of inadvertent exposure include hypoglycaemia, nausea, vomiting, and abdominal pain, and can be serious in infants.
• Liver disease: If the formulation contains ethanol (alcohol) or other hepatically metabolised ingredients, caution is needed in patients with severe liver impairment, especially during prolonged use.
• Pre-existing oral or throat disorders: Recurrent candidiasis, a history of oropharyngeal malignancy, or post-radiotherapy mucositis can complicate the interpretation of new or persistent symptoms. Discuss these with your doctor before self-administering throat preparations.
• Immunocompromise: People receiving chemotherapy, immunosuppressive therapy after transplantation, or high-dose corticosteroids can develop serious throat infections that mimic simple sore throat. Any new throat pain in these patients should be evaluated promptly.
• Concurrent use of other oropharyngeal products: Using multiple throat sprays, gargles, or lozenges at the same time can increase mucosal irritation and may disturb normal taste, salivary function, and the balance of commensal oral flora.

Pregnancy and Breastfeeding

Safety data on Streplieve in pregnancy and breastfeeding are limited. Because the active substances act locally, systemic exposure at recommended doses is expected to be low, but as with all medicines in pregnancy, a precautionary approach is appropriate. In general, non-pharmacological measures such as adequate hydration, humidified air, warm drinks, and saline gargles should be tried first. If symptoms remain troublesome, discuss the use of Streplieve with your doctor or midwife, who will weigh expected benefits against any theoretical concerns in your individual situation.

For breastfeeding women, the small systemic exposure expected from a topical throat preparation makes passage into breast milk unlikely to be clinically significant. Nevertheless, any new medicine should be introduced in agreement with your healthcare provider, and any unusual symptoms in the infant (rash, irritability, feeding difficulty) should prompt review.

Children

Throat preparations containing local anaesthetic components are generally not recommended in young children because of the risk of impairing the protective swallowing reflex, increasing the chance of aspiration. Streplieve should only be used in children if specifically prescribed by a doctor and should never be administered below the minimum age stated on the package. Parents and caregivers should always measure the dose using the graduated measuring device supplied with the syrup, never household teaspoons, which can vary considerably in volume.

Driving and Using Machines

Streplieve has no or negligible influence on the ability to drive or use machines when used as directed. Transient local numbness of the mouth and throat does not typically affect cognitive performance. However, if the formulation contains ethanol, patients who are particularly sensitive to alcohol or who are taking medicines that interact with alcohol should be cautious, particularly at higher daily doses.

Excipient Warnings

How Does Streplieve Interact with Other Drugs?

As a locally acting throat preparation, Streplieve differs from systemic medicines in its interaction profile: there is no meaningful interference with hepatic cytochrome P450 enzymes, plasma protein binding, or renal transporters at normal therapeutic doses. However, several practical interactions are worth highlighting because they affect either the efficacy of Streplieve itself or the management of concomitant conditions.

Major Interactions

Minor and Practical Interactions

Tell your doctor or pharmacist about all medicines you are taking, including prescription medicines, over-the-counter products (including cough suppressants and decongestants), herbal or traditional remedies, and nutritional supplements. This is particularly important if you are taking anticoagulants such as warfarin, immunosuppressants, chemotherapy, or antiretroviral therapy, since acute illness itself can alter the pharmacokinetics of these critical medicines.

What Is the Correct Dosage of Streplieve?

Because dosing can vary between markets and between specific Streplieve formulations, the following information is presented as a clinically typical framework for throat syrups in this class. Patients must always refer to the specific package leaflet of their own prescription for the definitive schedule.

Adults

For adults, Streplieve is typically taken several times daily as needed for throat discomfort, with doses spaced at least two hours apart to avoid cumulative mucosal irritation. The dose should be drawn up into the supplied measuring device (spoon or oral syringe), placed in the mouth, and allowed to coat the back of the throat for a few seconds before being swallowed. Patients who find the syrup too sweet or too concentrated can dilute it in a small amount of water, but this may slightly reduce the depth of the local effect.

Do not exceed the stated maximum daily dose or the stated maximum duration of treatment. If symptoms persist beyond the recommended duration of self-treatment — typically 3 to 5 days — a clinical review is required to exclude bacterial infection, glandular fever, or less common causes of persistent sore throat such as reflux pharyngitis, vocal strain, or more serious conditions.

Children and Adolescents

Streplieve should only be used in children if prescribed by a doctor and only from the minimum age stated in the package leaflet. In children, accurate dose measurement is particularly important: always use the measuring device supplied with the bottle, never household cutlery. Paediatric dosing is usually lower than the adult regimen and the maximum daily dose is correspondingly reduced. In very young children, throat preparations with local anaesthetic components are generally avoided because of the risk of suppressing the gag and swallow reflexes. Parents should also be mindful of the sugar content in paediatric syrups and encourage a rinse of the mouth with water after each dose, especially at bedtime, to reduce the risk of dental caries.

Elderly Patients

No specific dose reduction is typically required for healthy adults over 65 years of age. However, elderly patients are more likely to have polypharmacy, coexisting diabetes, or liver or renal impairment, and the implications of sugar- or alcohol-containing formulations may therefore be greater than in younger adults. A careful review of the full medication list by a pharmacist is always recommended when starting a new medicine in older patients.

Renal and Hepatic Impairment

Because Streplieve acts primarily locally and systemic exposure is low at recommended doses, there are generally no dose adjustments required for impaired renal function. In severe hepatic impairment, the small amount of ingested active substance is unlikely to cause harm, but formulations containing ethanol, benzoic acid, or other hepatically metabolised excipients should be used with caution and ideally avoided.

Missed Dose

If a dose is missed, simply take the next dose when symptoms require, as long as the stated minimum interval since the previous dose has elapsed. Do not take a double dose to compensate for a missed one, because this can exceed the maximum daily limit and increase the risk of mucosal irritation or excipient-related adverse effects.

Overdose

Accidental overdose of Streplieve oral syrup is usually mild, because systemic absorption remains limited even at slightly higher doses. Symptoms may include local numbness of the mouth and throat, nausea, mild drowsiness, headache, and in the case of sugar- or sorbitol-containing formulations, gastrointestinal symptoms such as diarrhoea or abdominal bloating. Very large accidental ingestions, particularly in children, may cause more pronounced effects and should be assessed by a healthcare professional or through a national poisons information service.

How to Take Streplieve Correctly

1. Shake the bottle gently before use, if directed by the leaflet, to ensure even distribution of active ingredients.
2. Measure the dose accurately using the measuring device supplied with the bottle — a graduated oral syringe, dosing cup, or spoon. Household cutlery is not accurate.
3. Place the syrup in the mouth and let it coat the back of the throat for several seconds before swallowing. Do not gargle unless the package leaflet specifically recommends it.
4. Swallow slowly, allowing the remaining syrup to continue coating the pharynx on the way down.
5. Avoid eating or drinking for 15–30 minutes after the dose to prolong contact time with the mucosa.
6. Replace the cap tightly after each use and store the bottle as directed (see storage section).
7. Rinse the measuring device with clean water and allow it to air-dry between uses.

What Are the Side Effects of Streplieve?

Like all medicines, Streplieve can cause side effects, although not everybody gets them. The adverse event profile of topical throat preparations is dominated by local effects in the mouth and pharynx, with systemic effects being uncommon and usually related to specific excipients (such as sorbitol, ethanol, or dye allergens) rather than to the active substances themselves. The vast majority of reactions are mild, self-limiting, and resolve within a few hours of stopping the medicine.

It is important to distinguish side effects of Streplieve from symptoms of the underlying illness. Sore throat, cough, mild fever, fatigue, headache, and nasal congestion are common features of the viral infections for which Streplieve is most often prescribed, and should not be attributed to the syrup itself. If there is any doubt, contact your doctor or pharmacist for clarification.

Side Effects by Frequency

Understanding Local Numbness

If the specific formulation of Streplieve you have been prescribed contains a local anaesthetic component, it is normal to experience a short-lived numb or tingling sensation in the mouth and throat after each dose. This effect typically peaks within a few minutes of swallowing and resolves within 30 to 60 minutes. During the period of numbness, it is important to be careful when eating or drinking hot food or liquids, as the usual protective sensation of heat is temporarily reduced, raising the risk of oral burns. Children should be supervised during this period.

Effects on Oral Flora

Because topical antiseptics reduce bacterial numbers on the mucosa, prolonged use can alter the balance of normal oral flora. This can occasionally lead to the overgrowth of Candida albicans, which manifests as white patches on the tongue, palate, or inner cheeks, sometimes accompanied by soreness and a burning sensation. Risk factors include immunocompromise, diabetes, denture wear, inhaled corticosteroid use, and prolonged courses of throat preparations. If suspected, an oral antifungal medicine may be required.

Allergic Reactions

Although rare, allergic reactions to throat preparations do occur, most often in relation to specific excipients (colourings, preservatives, flavourings, natural rubber components in the cap) rather than to the active therapeutic substances. Mild reactions present as localised rash, lip swelling, or itching and usually resolve rapidly on stopping the medicine. Severe reactions involving airway compromise are a medical emergency and require immediate administration of adrenaline (epinephrine) and emergency service transfer.

Reporting Side Effects

How Should You Store Streplieve?

Correct storage is important to preserve the potency of the active substances and to protect against microbial contamination. Liquid oral formulations are intrinsically more vulnerable than solid dosage forms because water provides a medium in which chemical degradation and microbial growth can occur more rapidly. Streplieve is typically formulated with preservatives designed to maintain sterility for a defined in-use period, but these protections can be overwhelmed by improper storage.

• Store at room temperature below 25 °C (or as directed on the package). Do not expose the bottle to direct sunlight, radiators, or other heat sources.
• Do not freeze: freezing can cause crystallisation of sugar or sorbitol, separation of oils from the syrup base, and precipitation of actives, permanently affecting the product.
• Keep the bottle tightly closed when not in use, both to prevent evaporation and to minimise microbial contamination.
• Keep away from sources of moisture such as bathroom shelves or kitchen areas near steam. Ideally store in a cool, dry cupboard.
• Store in the original container: do not transfer to other containers that may alter the product’s light and moisture protection or cause confusion with other medicines.
• Check the expiration date before every use. Discard any syrup that has expired or whose appearance, smell, or taste has changed substantially.
• In-use shelf life: once the bottle is opened, use within the in-use period printed on the carton or leaflet — typically 4–8 weeks. After this time, discard even if some liquid remains.
• Keep out of reach of children: sweet-tasting syrups can be attractive to children and accidental ingestion is a recognised cause of paediatric poisoning calls. Use child-resistant caps and high-shelf storage.

What to Do With Unused Medicine

Unused or expired Streplieve syrup should not be disposed of via wastewater or household waste. Pharmaceuticals that enter the environment through drains or landfill can contribute to pollution of waterways and accumulation of pharmacological agents in ecosystems. Return unwanted syrup to a pharmacy for safe destruction, in accordance with local environmental regulations. Most countries operate free pharmacy-based medicine disposal schemes.

Travel Considerations

If you need to travel during a short course of Streplieve, carry the bottle in your hand luggage in its original carton so that it remains at a stable temperature and is protected from accidental damage or freezing in cargo holds. Patients travelling to hot climates should note that temperatures in parked vehicles, beach bags, and pool-side cabinets can easily exceed recommended storage limits. An insulated bag may be helpful during the journey, but the bottle should not be placed in direct contact with ice packs.

What Does Streplieve Contain?

Understanding the complete composition of Streplieve is important for patients with known allergies, intolerances, dietary restrictions, or religious or ethical preferences concerning certain excipients (for example gelatine, pork-derived products, or alcohol). Healthcare professionals also need accurate composition data when assessing compatibility with other medicines, particularly in paediatric, pregnant, or elderly patients.

Active Substance

The active substances of Streplieve are listed on the outer carton and in the package leaflet. Throat preparations in this class typically combine a topical antiseptic (such as cetylpyridinium chloride, dichlorobenzyl alcohol, amylmetacresol, or hexylresorcinol), a local anaesthetic or counter-irritant (such as lidocaine, benzocaine, or menthol), and sometimes additional soothing agents (glycerol, honey). The exact combination determines the nuances of onset, duration, and taste, as well as age restrictions and the interaction profile.

Other Ingredients (Excipients)

The excipient list for an oral syrup in this class typically includes the following components, though the presence and quantity of each depends on the specific marketed formulation:

• Purified water — solvent
• Sucrose, glucose, or sorbitol (E420) — sweetening agent and tonicity modifier; contributes to the demulcent effect
• Glycerol — humectant and demulcent that soothes the mucosa and extends local contact time
• Ethanol — solvent for certain active substances; may be present in low concentrations
• Citric acid and sodium citrate — pH buffer
• Natural or artificial flavourings — to improve palatability (lemon, honey, menthol, eucalyptus)
• Food-grade colourings — for visual identification; azo dyes should be noted in allergy-prone patients
• Parabens, benzoic acid, or potassium sorbate — preservatives to prevent microbial growth during in-use life

Check the specific package leaflet of your prescription for the definitive list of ingredients and quantities per millilitre.

Appearance and Packaging

Streplieve is typically supplied as a clear to lightly coloured, viscous oral syrup with a pleasant flavour designed for palatability. It is packaged in amber-glass or opaque plastic bottles to protect the formulation from light. Each carton contains one bottle with a child-resistant cap, a tamper-evident seal, and a graduated measuring device (either an oral syringe or a measuring cup calibrated in millilitres).

Bottle sizes vary by market but commonly include 50 ml, 100 ml, 150 ml, and 200 ml presentations. Not all pack sizes may be marketed in every country. The marketing authorisation holder and manufacturer are named on the outer carton and in the package leaflet.

Animal-Derived Ingredients and Dietary Considerations

Certain excipients used in liquid oral medicines can be derived from animal sources. For example, flavouring systems may occasionally include ingredients of animal origin, and the capsule-type presentations of related products may contain gelatine. Vegetarians, vegans, and patients with religious dietary restrictions should ask their pharmacist to confirm the origin of excipients before starting treatment. Where an acceptable alternative is needed, a different throat preparation or a sugar-free, alcohol-free, animal-product-free formulation can usually be identified.

References

This article is based on evidence from internationally recognised medical sources. All information has been reviewed for accuracy against current clinical guidelines and peer-reviewed research.

1. European Medicines Agency (EMA). Summary of Product Characteristics (SmPC) – general guidance on oropharyngeal preparations. Available at ema.europa.eu.
2. U.S. Food and Drug Administration (FDA). Nonprescription and Prescription Throat Preparations: General Guidance. Silver Spring, MD: FDA, Center for Drug Evaluation and Research.
3. British National Formulary (BNF). Drugs used in the mouth and throat. National Institute for Health and Care Excellence (NICE). Available at bnf.nice.org.uk.
4. National Institute for Health and Care Excellence (NICE). Sore throat (acute): antimicrobial prescribing. NICE guideline [NG84]. London: NICE, 2018 (updated 2023).
5. Shulman ST, Bisno AL, Clegg HW, et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2012;55(10):e86-e102. doi:10.1093/cid/cis629
6. Pelucchi C, Grigoryan L, Galeone C, et al. Guideline for the management of acute sore throat. ESCMID Sore Throat Guideline Group. Clin Microbiol Infect. 2012;18(Suppl 1):1-28.
7. Oxford JS, Leuwer M. Acute sore throat revisited: clinical and experimental evidence for the efficacy of over-the-counter AMC/DCBA throat lozenges. Int J Clin Pract. 2011;65(5):524-530.
8. Wade AG, Morris C, Shephard A, Crawford GM, Goulder MA. A multicentre, randomised, double-blind, single-dose study assessing the efficacy of AMC/DCBA warm lozenge or AMC/DCBA cool lozenge in the relief of acute sore throat. BMC Fam Pract. 2011;12:6. doi:10.1186/1471-2296-12-6
9. Spinks A, Glasziou PP, Del Mar CB. Antibiotics for sore throat. Cochrane Database Syst Rev. 2021;12:CD000023. doi:10.1002/14651858.CD000023.pub5
10. Chenot JF, Weber P, Friede T. Efficacy of Ambroxol lozenges for pharyngitis: a meta-analysis. BMC Fam Pract. 2014;15:45. doi:10.1186/1471-2296-15-45
11. Worrall G. Acute sore throat. Can Fam Physician. 2011;57(7):791-794.
12. World Health Organization (WHO). WHO Model List of Essential Medicines – 23rd List (2023). Geneva: World Health Organization.
13. European Medicines Agency (EMA). Guideline on the pharmaceutical quality of inhalation and nasal products and comparable oromucosal products. EMEA/CHMP/QWP/49313/2005 Corr. 2014.
14. Eccles R. Mechanisms of the symptoms of rhinosinusitis. Rhinology. 2011;49(2):131-138.
15. Kenealy T, Arroll B. Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database Syst Rev. 2013;(6):CD000247. doi:10.1002/14651858.CD000247.pub3

Medical Editorial Team

This article was written and reviewed by the iMedic Medical Editorial Team, which includes board-certified physicians specialising in otorhinolaryngology, general practice, and clinical pharmacology. Our team follows international editorial standards and the GRADE evidence framework to ensure all medical information is accurate, current, and evidence-based.

Last reviewed: January 16, 2026 | Next scheduled review: July 16, 2026